|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print June 21, 2002
Am J Physiol Heart Circ Physiol, 10.1152/ajpheart.00027.2002
Submitted on January 15, 2002
Accepted on June 12, 2002
1 Pharmacology, University of Arizona College of Medicine, Tucson, AZ, USA
* To whom correspondence should be addressed. E-mail: huberj{at}u.arizona.edu.
In this study, we examined the effect of
-carrageenan induced inflammatory pain on the functional and structural properties of the rat blood-brain barrier (BBB) over a 72 hr time period. Systemic inflammation was induced by an intraplantar injection of 3%
-carrageenan into the right hind paw of female Sprague-Dawley rats. In situ brain perfusion and Western blot analyses were performed at 1, 3, 6, 12, 24, 48, and 72 hr.
In situ brain perfusion showed
-carrageenan significantly increased brain uptake of [14C] sucrose at 1, 3, 6, and 48 hr [139 ± 9, 166 ± 19, 138 ± 13, and 146 ± 7% compared to control, respectively]. Capillary depletion analysis insured the increased brain uptake was due to increased paracellular permeability at the BBB and not vascular trapping. Western blot analyses for zonula occludens-1 (ZO-1) and occludin were performed on isolated cerebral microvessels. ZO-1 expression was significantly increased at 1, 3, and 6 hr and returned to control expression levels by 12 hr. Total occludin expression was significantly reduced at 1, 3, 6, 12, and 48 hr.
This investigation demonstrated
-carrageenan induced inflammatory pain elicits a biphasic increase in BBB paracellular permeability with the first phase occurring from 1-6 hr and the second at 48 hr. Furthermore, changes in BBB function are correlated with altered tight junctional protein expression of occludin and ZO-1. Changes in the structure of tight junctions may have important clinical ramifications concerning central nervous system homeostasis and therapeutic drug delivery.
This article has been cited by other articles:
![]() |
T. A. Brooks, N. Nametz, R. Charles, and T. P. Davis Diclofenac Attenuates the Regional Effect of {lambda}-Carrageenan on Blood-Brain Barrier Function and Cytoarchitecture J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 665 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Huber, C. R. Campos, K. S. Mark, and T. P. Davis Alterations in blood-brain barrier ICAM-1 expression and brain microglial activation after {lambda}-carrageenan-induced inflammatory pain Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H732 - H740. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Brooks, B. T. Hawkins, J. D. Huber, R. D. Egleton, and T. P. Davis Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H738 - H743. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Hawkins and T. P. Davis The Blood-Brain Barrier/Neurovascular Unit in Health and Disease Pharmacol. Rev., June 1, 2005; 57(2): 173 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Song, C. Pope, R. Murthy, J. Shaikh, B. Lal, and J. P. Bressler Interactive Effects of Paraoxon and Pyridostigmine on Blood-Brain Barrier Integrity and Cholinergic Toxicity Toxicol. Sci., April 1, 2004; 78(2): 241 - 247. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |